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ABSTRACT
Mutations in leucine-rich repeat kinase 2 (LRRK2) are associated
with Parkinson’s disease, but the precise physiological function of
the protein remains ill-defined. Recently, our group proposed a
model in which LRRK2 kinase activity is part of an EndoA
phosphorylation cycle that facilitates efficient vesicle formation at
synapses in the Drosophila melanogaster neuromuscular junctions.
Flies harbor only one Lrrk gene, which might encompass the
functions of both mammalian LRRK1 and LRRK2. We therefore
studied the role of LRRK2 in mammalian synaptic function and
provide evidence that knockout or pharmacological inhibition of
LRRK2 results in defects in synaptic vesicle endocytosis, altered
synaptic morphology and impairments in neurotransmission. In
addition, our data indicate that mammalian endophilin A1 (EndoA1,
also known as SH3GL2) is phosphorylated by LRRK2 in vitro at T73
and S75, two residues in the BAR domain. Hence, our results
indicate that LRRK2 kinase activity has an important role in the
regulation of clathrin-mediated endocytosis of synaptic vesicles and
subsequent neurotransmission at the synapse.
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INTRODUCTION
Leucine-rich repeat kinase 2 (LRRK2) is a large multidomain
protein harboring a kinase, GTPase and several protein-binding
domains (Cookson and Bandmann, 2010). Mutations in this protein
are linked to familial as well as sporadic forms of Parkinson’s
disease (Paisa´n-Ruı´z et al., 2004, Zimprich et al., 2004). For
example, the G2019S mutation, which causes elevated kinase
activity, is responsible for 4% of familial Parkinson’s disease
worldwide (Healy et al., 2008). Interestingly, this mutation was
also found in some apparently sporadic cases. Several other
mutations (e.g. R1441C/H/G and I2020T) in the GTPase and
kinase domains have also been shown to segregate with
Parkinson’s disease (Zimprich et al., 2004; Healy et al., 2008).
Despite the apparent clinical association between LRRK2
mutations and Parkinson’s disease, it remains enigmatic how
such mutations lead to disease progression and the biological
function of LRRK2 itself also still needs to be clarified further.
Although several proteins have been identified as kinase
substrates of LRRK2, none of these substrates have been
independently reported in vivo. Substrates are involved in
different processes, such as neuronal survival, cytoskeletal
rearrangement, autophagy and apoptosis (Berwick and Harvey,
2011; Gillardon, 2009; Plowey and Chu, 2011; Martin et al.,
2014). LRRK2 has also been shown to regulate
neurotransmission, by interacting with synaptic proteins that
modulate clathrin-mediated endocytosis of synaptic vesicles,
such as Rab5b, snapin and N-ethylmaleimide-sensitive factor
(NSF) (Piccoli et al., 2011; Shin et al., 2008; Yun et al., 2013;
Piccoli et al., 2014). Moreover, we revealed an essential role
for LRRK in synaptic vesicle endocytosis at Drosophila
melanogaster neuromuscular junctions through phosphorylation
of endophilin A (EndoA) (Matta et al., 2012). EndoA is an
evolutionary conserved protein involved in clathrin-mediated
endocytosis (Ringstad et al., 1997). It drives the formation of
synaptic vesicles by sensing or inducing plasma membrane
curvature (Gallop et al., 2006; Masuda et al., 2006) and
facilitates clathrin uncoating once synaptic vesicles are
generated (Milosevic et al., 2011; Verstreken et al., 2002).
Consequently, impairment of EndoA function results in severe
deficits in synaptic vesicle endocytosis (Gad et al., 2000;
Milosevic et al., 2011; Schuske et al., 2003; Verstreken et al.,
2002). Our study identified EndoA as a substrate of LRRK and
demonstrated that LRRK has an essential role in synaptic vesicle
endocytosis in Drosophila by phosphorylating EndoA at S75
(Matta et al., 2012).
Given that flies express only one LRRK protein, which might
encompass the function of both mammalian LRRK1 and
LRRK2, we specifically assessed the role of LRRK2 in
synaptic vesicle endocytosis in mammals. We demonstrate that
LRRK2 knockout leads to impairments in clathrin-mediated
synaptic vesicle endocytosis and neurotransmission and the
presence of endocytic intermediates and abnormal vesicle
morphology and number, similar to Lrrk knockout in
Drosophila. Furthermore, we show that mammalian EndoA1
(SH3GL2), a neuron-specific variant of EndoA (Giachino et al.,
1997), is a kinase substrate of LRRK2, confirming the
conservation between Drosophila and the mammalian system.
Finally, we show that LRRK2 phosphorylates EndoA1 not only on
residue S75, identical to the residue phosphorylated in Drosophila,
but on T73 as well. Taken together, our findings advance
the understanding of the evolutionary conserved biological
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function of LRRK2 and its pivotal role in clathrin-mediated
endocytosis.
RESULTS
Knockout of LRRK2 impairs mammalian synaptic
vesicle endocytosis
Our group recently reported that knockout of LRRK, the
Drosophila melanogaster orthologue of LRRK1 and LRRK2,
causes an impairment in clathrin-mediated endocytosis of
synaptic vesicles, indicating that there is a role for this protein
in synaptic vesicle formation (Matta et al., 2012). To determine
whether this role in endocytosis is contained within the LRRK2
protein, we performed dynamic assays of endocytosis in wild-
type and LRRK2-knockout primary striatal neurons by using
sypHy, a fusion construct of synaptophysin and super ecliptic
pHluorin. At the onset of stimulus (20 Hz for 15 s), exocytosis
caused a rapid increase in sypHy fluorescence (Fig. 1Aii)
which, after cessation of stimulus, slowly returned to baseline
(Fig. 1Aiii). As shown in Fig. 1B, the decay of fluorescence
was delayed in LRRK2-knockout cells when compared to wild-
type controls. The fluorescence decay, which reflects
endocytosis, was assessed by fitting the trace with a single
exponential time constant (tdecay). Quantification shows that
tdecay is significantly increased in LRRK2-knockout neurons
(wild-type, 68.9665.07; LRRK2 knockout, 89.2963.92;
mean6s.e.m., P,0.0001, Fig. 1C), indicating that endocytosis
of synaptic vesicles is impaired in these cells. However,
no significant differences in exocytosis were observed under
these conditions (wild-type, 10.0060.69; LRRK2 knockout,
9.3060.63; Fig. 1D). These results demonstrate that the role of
LRRK2 in synaptic vesicle endocytosis, a mechanism previously
identified in Drosophila Lrrk mutants, is conserved in
mammalian neurons.
LRRK2-knockout synapses present endocytic intermediates
and a reduced number of synaptic vesicles with
altered morphology
To gain insight into whether the endocytic delay observed in
mammalian LRRK2-knockout neurons could also be observed
at a morphological level, we performed transmission electron
microscopy (TEM) of wild-type (Fig. 2A) and LRRK2-knockout
(Fig. 2B–E) striatal brain sections. Ultrastructural analysis of
knockout synapses revealed a phenotype different from control
littermates: a decreased number of synaptic vesicles (Fig. 2B),
which were in general more heterogeneous in size with the presence
of vesicles with a larger diameter (Fig. 2C, asterisks). Abnormal
endocytic intermediates (Fig. 2D, asterisks), including clathrin-
coated endocytic intermediates (Fig. 2E), were also evident in some
knockout nerve terminals. Quantification of TEM micrographs
showed that the mean number of synaptic vesicles per mm2
synapse was substantially lower in knockout than in control
synapses (Fig. 2F, wild-type, 194.865.1; knockout, 146.064.6;
mean6s.e.m.; P,0.0001). In addition, the average synaptic vesicle
diameter was increased in LRRK2 knockouts compared to controls
(Fig. 2G, wild-type, 47.5960.47 nm; knockout 50.1560.48 nm,
P,0.001) and vesicles with a larger diameter were more abundant
in knockout than in control synapses (Fig. 2H). These observations
are reminiscent of the morphological changes we previously
described in Drosophila, where synaptic vesicle size was
increased in LRRK-knockout boutons (Matta et al., 2012).
Interestingly, a reduction in the number of synaptic vesicles and
accumulation of clathrin-coated vesicular profiles were also
Fig. 1. Knockout of LRRK2 causes defects in
synaptic vesicle endocytosis. (A) Representative
snapshots taken from 2 Hz recordings of SypHy-
expressing wild-type (WT) and LRRK2-knockout (KO)
neurons at rest (i), at maximal stimulation (ii) and
towards the end of recovery (iii). Scale bar: 20 mm.
(B–D) Slower endocytic recovery in LRRK2 KO neurons.
(B) Following the onset of stimulus (300 action potentials
at 20 Hz), exocytosis of sypHy caused a rapid
increase in fluorescence, followed by an exponential
decay after the cessation of stimulation, which was
delayed in LRRK2 KO cells. Grey lines indicate the
duration of the 20 Hz stimulus. Snapshot timepoints as
shown in Ai–iii are indicated by red circles.
(C) Quantification of the decay of fluorescence. Time
constant tdecay shows that endocytosis is delayed in
LRRK2 KO neurons (**P,0.01, Student’s t-test).
(D) Quantification of the increase in fluorescence. Time
constant tupstroke shows that exocytosis is not altered in
LRRK2 KO cells (ns, not significant). Data in C and D
are expressed as mean6s.e.m. derived from at least
three independent experiments and corrected for
differences in endocytosis in D.
observed in endophilin triple-knockout mouse synapses (Milosevic
et al., 2011) and in fly endoA-knockout boutons (Guichet et al.,
2002; Verstreken et al., 2002), suggesting that the morphological
defects observed in LRRK2 knockouts and mouse endophilin triple-
knockouts might be due to overlapping mechanisms.
Synaptic transmission is impaired in LRRK2-knockout
mammalian neurons
The previous findings prompted us to hypothesize that LRRK2 might
have an important role in synaptic function. To determine whether
knockout of LRRK2 affects neurotransmission, we measured the
number of spontaneous excitatory postsynaptic currents (sEPSCs) in
wild-type (n519) and LRRK2-knockout (n522) hippocampal
neurons. All neurons in culture appeared healthy and, under basal
conditions, the number of sEPSCs was similar in wild-type and
LRRK2-knockout cells (Fig. 3A). To measure sEPSCs coming from
newly formed synaptic vesicles, sucrose (50 mM) was added to the
bath solution as it stimulates the release of the readily releasable pool
through Ca2+-independent mechanical stress (Rosenmund and
Stevens, 1996). In sucrose-treated wild-type cells, the number of
sEPSCs was increased compared to non-treated wild-type cells
(control, 47.74614.03; sucrose, 100.8469.76; mean6s.e.m.). In
knockout cells, however, sucrose treatment failed to increase the
number of sEPSCs (control, 32.0568.07; sucrose, 43.1469.76;
Fig. 3B). The effect of sucrose on the number of sEPSCs was
calculated by determination of the sucrose versus control ratios
(wild-type, 4.0761.38; knockout, 1.6960.37; Fig. 3C). These data
indicate that LRRK2 modulates synaptic function, as knockout of
LRRK2 causes impairment in neurotransmission following the
release of the readily releasable pool.
To investigate this further, we verified whether the diminished
response to sucrose observed in LRRK2-knockout neurons is due
to impairments at the pre- or post-synaptic level. When analyzing
the frequency of sEPSCs, which is well known to be dependent
on the presynaptic machinery (Marinelli et al., 2003), we
observed differences between wild-type and LRRK2-knockout
neurons. Under basal conditions, the frequency was similar in
wild-type and LRRK2-knockout neurons, whereas the presence of
sucrose stimulated neurotransmitter release and significantly
increased the sEPSC frequency in wild-type (control,
26.3264.27; sucrose, 46.6466.48) but not in LRRK2-knockout
neurons (control, 35.4464.01; sucrose, 30.0064.67, Fig. 3D).
Analysis of sucrose versus control ratios (wild-type, 2.0860.33;
knockout, 0.9760.18; Fig. 3E) confirmed the increase in
frequency in wild-type neurons, but not in LRRK2-knockout
neurons. This indicates that LRRK2 has a role in the presynaptic
Fig. 2. Altered synaptic vesicle morphology and number
in LRRK2-knockout synapses. (A) Wild-type (WT)
synapse. (B,C) LRRK2-knockout (KO) synapses revealing a
decrease in the number of synaptic vesicles (B) and
heterogeneity in vesicle size (C) with the presence of some
abnormally large vesicles (asterisks in C). (D,E) LRRK2 KO
synapses occasionally showed aberrantly formed endocytic
intermediates (asterisks in D) or were entirely occupied by
less densely packed clathrin-coated vesicles (E). The inset in
E is a high-magnification view showing the clathrin-coated
vesicular profiles in more detail. Scale bars: 200 nm.
(F) Quantification of the vesicle density as number of
synaptic vesicles (SVs) per mm2 (**** P,0.0001, Student’s
t-test). (G) Quantification of the average synaptic vesicle
diameter (nm). Each data point represents the mean synaptic
vesicle diameter for a single terminal. At least 20 synaptic
vesicles were measured in each terminal (*** P,0.001,
Student’s t-test). (H) Frequency distribution of the synaptic
vesicle diameter (10 nm bins). Vesicles exceeding 80 nm in
diameter were four times more abundant in KO synapses (20
vesicles in KO versus five vesicles in WT). Data in F and G
are expressed as mean6s.e.m. and derived from at least
three independent experiments.
mechanisms that replenish the synaptic vesicle pool to govern
high frequency neurotransmission, consistent with a role in
endocytosis and vesicle recycling. To evaluate whether LRRK2
also affects the postsynaptic mechanisms, we measured the
sEPSC peak amplitude, of which changes are thought to reflect
changes in the response of the postsynaptic receptors (Sebe
et al., 2003; Thompson et al., 1993). As shown in Fig. 3F, there
were no differences in peak amplitude between control and
sucrose condition in wild-type (control, 225.9062.84; sucrose,
225.2762.47) or LRRK2-knockout cells (control, 219.4461.97;
sucrose, 218.2961.37). Calculation of the sucrose versus
control ratio (Fig. 3G) confirmed that the peak amplitude
remained unchanged (wild-type, 1.0960.17; knockout,
0.9960.06).
Taken together, these data indicate that LRRK2 modulates
neurotransmission at the presynaptic level. We believe these
effects are specific to loss of LRRK2 as we observed similar
defects in neurotransmission when wild-type neurons were
treated with LRRK2-IN-1, a well-defined LRRK2 kinase
inhibitor (Deng et al., 2011). Treating wild-type cells with
different concentrations of LRRK2-IN-1 attenuated the effect of
sucrose on the number and frequency of sEPSCs, when compared
to DMSO-treated cells (supplementary material Fig. S1). Again,
no effect on peak amplitude was observed (supplementary
material Fig. S1). These data indicate that the presynaptic
function of LRRK2 is dependent on its kinase activity.
LRRK2 knockout mimics the effects of dynasore treatment
Our data suggest that LRRK2 has a presynaptic role in
neurotransmission by affecting synaptic vesicle endocytosis. To
strengthen the previous results, we compared the effect of
LRRK2 knockout to the effect of independently blocking
endocytosis. To block endocytosis we treated wild-type
(control, n515; dynasore, n514) and LRRK2-knockout
(control, n512; dynasore, n514) hippocampal neurons with
dynasore (40 mM for 5 min, Fig. 4A), a cell-permeable small
Fig. 3. Knockout of LRRK2 affects neurotransmission by
impairing presynaptic function. (A) Representative whole-
cell patch-clamp recordings from wild-type (WT) and LRRK2-
knockout (KO) hippocampal neurons in control conditions and
in the presence of sucrose (50 mM). (B) In control conditions,
the number of sEPSCs was similar in both genotypes, whereas
it was significantly increased in WT, but not in LRRK2 KO
neurons in the presence of sucrose. (C) Quantification of fold
change in the number of sEPSCs indicates that sucrose
induces a significant change in WT, but not in LRRK2 KO
neurons. (D) The frequency (Hz) of sEPSCs was similar in both
genotypes in control conditions, whereas it was significantly
increased in WT, but not in LRRK2 KO neurons in the presence
of sucrose. (E) Quantification of fold change in frequency of
sEPSCs indicates that sucrose induces a significant change in
WT, but not in LRRK2 KO neurons. (F) The mean peak
amplitude in WT and LRRK2 KO neurons in control conditions
and in the presence of sucrose. Although differences in current
amplitudes are observed between WTand LRRK2 KO cultures,
the presence of sucrose does not affect amplitude in either
genotype. (G) Analysis of fold change in peak amplitude
confirmed that sucrose had no effect in both genotypes. Data
are expressed as mean6s.e.m. (*P,0.05, Student’s t-test).
molecule that is a noncompetitive inhibitor of dynamin 1
(Douthitt et al., 2011; Macia et al., 2006).
Similar to previous data, the presence of sucrose caused an
increase in the number of sEPSCs in vehicle pretreated wild-type
(control, 24.8066.35; sucrose, 62.73617.21; mean6s.e.m.),
but not in LRRK2-knockout neurons (control, 45.09614.00;
sucrose, 51.09612.89, Fig. 4B). Pretreatment with dynasore
abolished the effect of sucrose in wild-type neurons (control,
119.57631.76; sucrose, 147.36634.02), but did not cause
differences in LRRK2-knockout neurons (control, 97.56615.00;
sucrose, 139.75630.78, Fig. 4B). Calculation of the sucrose
versus control ratios (wild-type control, 3.7760.66; wild-type
dynasore-treated, 1.7260.25; knockout control, 1.5560.23;
knockout dynasore-treated, 1.8260.40; Fig. 4C) confirmed
these results. To ensure that we were looking at presynaptic
changes, the frequency and peak amplitude of sEPSCs were
Fig. 4. LRRK2 knockout mimics the effects of dynasore treatment. (A) Representative whole-cell patch-clamp recordings from wild-type (WT) or LRRK2-
knockout (KO) hippocampal neurons in control (0.2% DMSO) conditions or upon treatment with dynasore (40 mM). (B) In control conditions, the presence of
sucrose (50 mM) significantly increased the number of sEPSCs in WT, but not in LRRK2 KO neurons. Although treatment with dynasore increased the
number of sEPSCs in both genotypes, it abolished the effect of sucrose in WT neurons. (C) Quantification of fold change in number of sEPSCs indicates that
treatment of WT neurons with dynasore mimics the lack of effect of sucrose observed in LRRK2 KO cells. (D) The frequency of sEPSCs was significantly
increased in WT, but not in LRRK2 KO neurons in the presence of sucrose in control conditions. Although treatment with dynasore increased the frequency of
sEPSCs in both genotypes, it abolished the effect of sucrose in WT neurons. (E) Quantification of fold change in the frequency of sEPSCs indicates that
treatment of WT neurons with dynasore mimics the lack of effect of sucrose observed in LRRK2 KO cells. (F,G) Treatment with dynasore did not affect peak
amplitude in either genotype. Data are expressed as mean6s.e.m. *P,0.05 versus WT DMSO treated, two-tailed Student’s t-test.
analyzed. In control conditions, the frequency of sEPSCs was
increased in the presence of sucrose in wild-type (control,
18.9864.05; sucrose, 35.3766.43) but not in LRRK2-knockout
neurons (control, 29.6664.74; sucrose, 33.1065.70, Fig. 4D).
Such increase was not present in dynasore-treated cells of either
genotype (wild-type control, 48.3066.52; wild-type with sucrose,
54.1765.61; knockout control, 40.6066.38; knockout with
sucrose, 46.1567.66, Fig. 4D). Analysis of the sucrose versus
control frequency ratios further strengthened these observations
(wild-type control, 2.6360.47; wild-type dynasore-treated,
1.3360.18; knockout control, 1.1160.17; knockout dynasore-
treated, 1.1860.10, Fig. 4E). Peak amplitude was not altered
in the presence of sucrose (wild-type control, 222.6962.76;
wild-type with sucrose, 226.1863.68; knockout control,
220.5663.24; knockout with sucrose 222.2764.50, Fig. 4F)
and treatment with dynasore did not affect this parameter
(wild-type control, 219.1362.63; wild-type with sucrose,
220.4863.19; knockout control, 223.6262.55; knockout with
sucrose, 222.4262.50; Fig. 4F). Analysis of the sucrose versus
control ratios confirmed this observation (wild-type control,
1.1460.05; wild-type dynasore-treated, 1.0560.03; knockout
control, 1.1560.25; knockout dynasore-treated, 0.9660.05,
Fig. 4G).
Human LRRK2 phosphorylates mammalian EndoA1 in vitro
We revealed a clear phenotype in LRRK2-knockout neurons,
with impairments in clathrin-mediated synaptic vesicle
endocytosis and neurotransmission, and the presence of
endocytic intermediates and abnormal vesicle morphology and
number. Recently, we reported a similar phenotype in Drosophila
as the result of changes in LRRK-dependent phosphorylation of
EndoA and we specifically identified the serine residue located at
position 75 as a LRRK-dependent phosphorylation site (Matta
et al., 2012). EndoA is an evolutionary conserved membrane-
interacting protein that is widely known to play a role in
endocytosis (Milosevic et al., 2011; Verstreken et al., 2002).
When comparing the sequences of EndoA in Homo sapiens, Mus
musculus, Rattus norvegicus and Drosophila melanogaster, we
noticed that the S75 residue is highly conserved across species
(Fig. 5C). Hence, we questioned whether LRRK2 can also
phosphorylate EndoA in mammals. To determine whether
human LRRK2 phosphorylates the mammalian EndoA1, the
neuron-specific EndoA isoform (Giachino et al., 1997; Milosevic
et al., 2011), we performed an in vitro [33P]ATP phosphorylation
assay with the following recombinant proteins: wild-type
EndoA1, EndoB1, which lacks the S75 residue and EndoA1
S75A, in which the serine residue is mutated to an alanine
residue. As shown in Fig. 5A, there is a time-dependent increase
in phosphorylation of EndoA1 and, to a lesser extent, in the
EndoA1 S75A mutant. Even less 33P incorporation was observed
in EndoB1. Consistently, quantification of the phosphorylated
versus total substrate ratios indicated that phosphorylation was
less efficient when the S75 residue was mutated into an alanine
residue or was not present (Fig. 5B). An in vitro [33P]ATP
Fig. 5. LRRK2 phosphorylates EndoA1 in vitro at S75. (A) Autoradiographs of in vitro LRRK2 kinase reactions using human wild-type endophilin A1
(EndoA1), S75A mutated endophilin A1 (EndoA1 S75A) and endophilin B1 (EndoB1) as substrates for the indicated times. Total protein was determined by
western blotting. (B) Quantification of the ratios of [33P]ATP signal in A shows decreased phosphorylation levels in EndoA1 S75A and EndoB1 compared to
EndoA1. Data are expressed as mean6s.e.m. and are representative of at least three independent experiments. ***P,0.001, two-way ANOVA with Bonferroni
post-tests. (C) Alignment of fruit fly, rat, mouse and human EndoA1, EndoA1 S75A and EndoB1 around S75 indicates that S75 is widely conserved across
species, whereas T73 is only conserved in mammals.
phosphorylation assay with recombinant wild-type, kinase
hyperactive G2019S or kinase deficient D1994A LRRK2 as
kinases and recombinant EndoA1 as a substrate shows that
EndoA1 phosphorylation was enhanced using G2019S LRRK2,
but almost completely abolished with the D1994A LRRK2
variant (supplementary material Fig. S2A,B). To address the
specificity of LRRK2-dependent EndoA1 phosphorylation we
compared LRRK2 and GSK3b as EndoA1 kinases in vitro. In this
phosphorylation assay GSK3b, unlike LRRK2, was not able to
phosphorylate EndoA1, although its autophosphorylation was
more prominent in comparison to LRRK2 (supplementary
material Fig. S2C,D). These observations provide further
evidence that EndoA1 is not a universal in vitro substrate for
the majority of kinases, supporting the specificity of the LRRK2-
driven phenomenon.
The previous analysis indicated that LRRK2 phosphorylates
EndoA1 at S75, but suggested this is not the only LRRK2-
dependent phosphorylation site in EndoA1. Thus, we
hypothesized that T73, which is also conserved in the
mammalian protein, but not present in Drosophila EndoA nor
mammalian EndoB1 (Fig. 5C) might be another LRRK2-
dependent phosphorylation site, as it is positioned in the same
functional domain as S75 (Fig. 6A,B). In order to test whether
EndoA1 has a dual LRRK2-dependent phosphorylation site at
T73 and S75, we performed an additional in vitro [33P]ATP
phosphorylation assay with wild-type EndoA1 and the T73A,
S75A and T73A/S75A mutant proteins as substrates. Data in
Fig. 6C confirm our hypothesis and show that LRRK2-mediated
phosphorylation of EndoA1 was diminished to the same extent by
mutating the T73 or the S75 residue (Fig. 6D). As expected,
phosphorylation of the double mutant EndoA1 was also
significantly decreased in comparison to wild-type EndoA1.
However, phosphorylation of double mutant EndoA1 was not
significantly different from phosphorylation of T73A or S75A
EndoA1. We speculate that this is because mutating either site
changes the conformation of the protein, meaning LRRK2 is
unable to phosphorylate the other residue. Although our data
indicate that the T73/S75 site is crucial for LRRK2-mediated
phosphorylation of EndoA1, we cannot rule out other
phosphorylation events in vitro.
DISCUSSION
In the present study, we reveal a role for LRRK2 at the
mammalian synapse and provide evidence that the function of
LRRK in the regulation of endocytosis in flies overlaps with the
role of mammalian LRRK2 in this process. We show that
knockout of LRRK2 impairs clathrin-mediated synaptic vesicle
endocytosis and neurotransmission. In line with this, previous
work by our group provided evidence for the involvement
of LRRK in synaptic vesicle endocytosis in Drosophila
melanogaster. We identified Drosophila EndoA as a substrate
of LRRK2 and through rescue experiments using Drosophila
EndoA mutants, we demonstrated that LRRK-dependent EndoA
phosphorylation regulates EndoA membrane affinity and
Fig. 6. LRRK2 phosphorylates EndoA1 in vitro at T73 and S75. (A,B) Three-dimensional model of a mouse EndoA1 dimer highlighting the location of T73
and S75 in the BAR domain. (A) Top view of a mouse EndoA1 dimer with helix1 appendages in green. Arrow indicates viewing direction from B. (B) A front view
of the same EndoA1 dimer is shown. (C) Autoradiographs of in vitro LRRK2 kinase reactions using human wild-type, S75A, T73A and T73A/S75A mutant
endophilin A1 as substrates during the indicated time points. Total protein was determined by western blotting. (D) Quantification of the ratios of the [33P]ATP
signal and total protein in C shows that phosphorylation is significantly decreased in all mutant forms of EndoA1 when compared to wild-type (WT) EndoA1 after
60 min of incubation. Data are expressed as mean6s.e.m. and representative of at least three independent experiments. **P,0.01; ***P,0.001, two-way
ANOVA with Bonferroni post-tests.
consequently modulates synaptic endocytosis (Matta et al., 2012).
Here, we show that, like the Drosophila variant, mammalian
EndoA1 is also phosphorylated by LRRK2, suggesting that the
signaling cascade regulating synapse function translates from fly
to mammalian neurons.
We provide evidence for a role for LRRK2 in endocytosis in
mammalian cells. Our data indicate that knockout of LRRK2
causes a significant impairment in clathrin-mediated endocytosis
in striatal neurons, in agreement with our observations in
Drosophila LRRK-knockout neurons and previous studies in
hippocampal neurons treated with short hairpin RNA (shRNA)
(Matta et al., 2012; Shin et al., 2008). Impaired rates of
endocytosis have also been observed in experiments with
regulators of endocytosis such as amphiphysin, endophilin,
SPIN90 and dynamin (Di Paolo et al., 2002; Kim et al., 2005;
Milosevic et al., 2011; Newton et al., 2006; Ferguson et al.,
2007). Clathrin-mediated endocytosis is a dynamic process in
which numerous proteins act as effectors and/or regulators. The
function of many of these proteins depends on interactions with
other proteins and thus, the removal of a specific protein can
impair the cascade of protein–protein interactions and
consequently affect endocytosis. Therefore, it is plausible that
the lack of LRRK2 alters clathrin-mediated endocytosis by
impairing the function of one or more endocytic proteins.
Recently, it has been described that LRRK2 could also
modulate synaptic vesicle exocytosis, either by regulating
presynaptic vesicle release or by interacting with snapin
(Piccoli et al., 2011; Yun et al., 2013). Yun and colleagues
claimed that LRRK2-dependent phosphorylation of snapin
decreased the extent of exocytotic release in hippocampal
neurons as measured by using vGlut-phluorin assays. However,
an earlier study from the same group failed to show an effect of
LRRK2 knockdown on synaptic vesicle exocytosis (Shin et al.,
2008). Our data in striatal neurons are in line with this study (Shin
et al., 2008), as we do not observe any effect on synaptic vesicle
exocytosis in LRRK2-knockout neurons. The use of different
neuronal populations (hippocampal vs striatal) and different
systems to measure exocytosis (vGlut-phluorin versus sypHy)
could possibly explain these divergences.
Our findings that LRRK2 affects endocytosis prompted us to
hypothesize that LRRK2 consequently might have an important
role in neurotransmission. Indeed, we observe that knockout of
LRRK2 leads to impaired presynaptic function upon sucrose
stimulation. As all sEPSCs measured after sucrose perfusion are
coming from newly formed vesicles, it is tempting to speculate
that this impairment in neurotransmission is driven by defects in
synaptic vesicle endocytosis. Hence, we propose that slowed
synaptic vesicle endocytosis in LRRK2-knockout neurons might
be the cause of impaired neurotransmission, especially during
intense neuronal activity, where the vesicle replenishment is
crucial for effective neurotransmitter release. In fact, we found
similar effects in synaptic transmission when cells are treated
with dynasore, a compound that has been demonstrated to inhibit
endocytosis through dynamin-dependent and -independent
mechanisms (Macia et al., 2006; Park et al., 2013). Hence, as
results in LRRK2-knockout neurons are similar to results seen
in dynasore-treated neurons, it is likely that these results are
also due to the effect of LRRK2 knockout on endocytosis.
Interestingly, treatment with dynasore increased the number of
sEPSCs detected in both genotypes in the presence and absence
of sucrose. This could be explained by an increase in transmitter
release, as dynasore has been described to elevate resting
intra-terminal Ca2+ concentrations, causing an increase in the
probability of transmitter release (Chung et al., 2010; Douthitt
et al., 2011).
In addition, pharmacological inhibition of LRRK2 kinase
activity with LRRK2-IN-1 causes similar impairments in
synaptic transmission, indicating that such impairments are, at
least partially, dependent on the LRRK2 kinase domain.
However, one needs to keep in mind possible off-target effects
of LRRK2-IN-1, as it has been previously shown that in
LRRK2-knockout neurons the effect of LRRK2-IN-1 mimics the
effect of LRRK2 ablation (Luerman et al., 2014). Further studies
in LRRK2-knockout neurons would be needed to shed light on
possible off-target effects of LRRK2-IN-1 on synaptic vesicle
endocytosis. Interestingly, synaptic transmission is also impaired
in mouse triple-knockout neurons of endophilin, an important
regulator of synaptic vesicle endocytosis (Milosevic et al.,
2011). In line with our data, an in vivo study in LRRK2
mutant animals has suggested an involvement of LRRK2 in
neurotransmitter release (Tong et al., 2009). Our data further
suggest that this function of LRRK in flies is mediated by
LRRK2 and not LRRK1 in the mammalian system, as LRRK2-
IN-1 does not inhibit LRRK1 kinase function (Kramer et al.,
2012). Future studies in LRRK1-knockout neurons could
strengthen this hypothesis further.
Defects in clathrin-mediated endocytosis can also be observed
at the ultrastructural level. LRRK2-knockout synapses show a
decreased number of synaptic vesicles that are heterogeneous in
size and present various aberrant endocytic intermediates,
including clathrin-coated intermediates. Similar phenotypes are
observed after inhibition of dynamin function using dynasore
(Newton et al., 2006) and in Drosophila mutants of endocytic
proteins such as EndoA, AP-180/lap, StonedB and Intersectin/
Dap160 (Dickman et al., 2005; Koh et al., 2004; Verstreken et al.,
2002; Verstreken et al., 2003; Zhang et al., 1998; Ferguson et al.,
2007; Guichet et al., 2002). These observations are also similar to
the morphological changes described in Lrrk Drosophila mutants,
where synaptic vesicle diameter was increased in knockout
boutons (Matta et al., 2012). Furthermore, a reduction in the
number of synaptic vesicles and an accumulation of clathrin-
coated vesicular profiles are also observed in endophilin triple-
knockout mice (Milosevic et al., 2011). As the ultrastructural
defects observed in these mice are very similar in LRRK2 and
endophilin-knockout synapses, one could speculate that LRRK2
regulates endophilin function during endocytosis in mammals.
Interestingly, a decreased number of synaptic vesicles was also
reported in a knockout model of a-synuclein, another protein
involved in Parkinson’s disease (Cabin et al., 2002) that is
reported to have a role in clathrin-mediated endocytosis (Ben
Gedalya et al., 2009). In addition, endophilin has also been
reported to bind with high affinity to Parkin, another protein
linked to Parkinson’s disease (Trempe et al., 2009). Therefore,
one could speculate that LRRK2, a-synuclein and Parkin function
in a common pathway at the synapse and disturbances of this
pathway have a role in Parkinson’s disease. Interestingly, defects
in synaptic transmission are frequently and consistently observed
in both dominant and recessive forms of Parkinson’s disease
(Kitada et al., 2009; Nakamura and Edwards, 2007; Tong et al.,
2009), although the molecular mechanisms remain unknown.
Further studies are now needed to determine whether this
intriguing common synaptic function of LRRK2 and other
Parkinson’s disease risk factors contributes to Parkinson’s
disease pathology associated with these genes.
In summary, our data reveal a clear phenotype in LRRK2-
knockout neurons, with slowed clathrin-mediated endocytosis,
impaired neurotransmission and ultrastructural abnormalities. As
mentioned before, similar phenotypes are observed in both
Drosophila EndoA and Drosophila Lrrk mutants and in
endophilin-knockout mice (Matta et al., 2012; Milosevic et al.,
2011; Verstreken et al., 2002). As such phenotypes in Lrrk
Drosophila mutants are the result of changes in LRRK-dependent
phosphorylation of EndoA (Matta et al., 2012), we aimed at
studying whether LRRK2 also phosphorylates mammalian
EndoA1. In this study, we provide in vitro evidence that
EndoA1 is phosphorylated by LRRK2 on at least two sites, T73
and S75. It is possible that additional serine and/or threonine
residues in EndoA1 are phosphorylated by LRRK2, because the
T73A/S75A mutant protein is still phosphorylated by LRRK2 in
vitro. The observation that GSK3b did not phosphorylate EndoA1
suggests that EndoA1 is only phosphorylated by specific kinases,
including LRRK2. The fact that LRRK2 does not phosphorylate
EndoB1, indicates that LRRK2 has a discrete number of selective
substrates.
Both T73 and S75 are located in the EndoA1 BAR domain,
which is known for its involvement in membrane curvature
(Gallop et al., 2006) and is highly conserved across species.
Interestingly, recent evidence indicates that the phosphorylation
of S75 constitutes a regulatory mechanism for guiding the
curvature state of EndoA1 and could be used to control different
types of membrane curvature in vivo (Ambroso et al., 2014). This
phenomenon was also observed in our previous study (Matta
et al., 2012). Hence, we suggest that LRRK2-dependent
phosphorylation of this site regulates the membrane affinity of
EndoA1 and consequently its role in clathrin-mediated
endocytosis. However, it will be essential to provide evidence
that LRRK2 also phosphorylates EndoA1 in vivo. Further
research will need to be conducted to resolve this issue.
Whether phosphorylation of T73 has a similar function to that
of S75 phosphorylation remains to be determined. Compared to
autophosphorylation of LRRK2, phosphorylation of EndoA1
appears to be low. However, LC-MS/MS data show that whereas
in EndoA1 only T73 and S75 were detected as phosphosites, in
LRRK2 more than 20 phosphosites were detected (supplementary
material Table S1), explaining the difference in 33P incorporation.
Furthermore, it needs to be kept in mind that the amount of
phosphorylation is not directly correlated with functionality in
vivo. Besides driving the formation of synaptic vesicles through
sensing or inducing plasma membrane curvature (Gallop et al.,
2006; Masuda et al., 2006), EndoA1 has another important
function in synaptic vesicle endocytosis, that is, facilitating
clathrin uncoating once synaptic vesicles have been generated
(Milosevic et al., 2011; Verstreken et al., 2002). Morphological
phenotypes found in LRRK2-knockout synapses suggest that both
EndoA1 functions might be affected. Nevertheless, further work
is needed to determine precisely how EndoA1 is affected by
LRRK2 in vivo. For example, similar to what was performed
before in Drosophila (Matta et al., 2012), it would be interesting
to use phosphomimetic or phosphodeficient EndoA1 mutants to
investigate whether expression of these mutants would rescue or
worsen the endocytosis deficiency phenotype that is observed in
LRRK2-knockout neurons. This would further strengthen our
hypothesis that LRRK2-dependent EndoA1 phosphorylation is
functionally important in synaptic vesicle endocytosis.
In this study, we look at effects of LRRK2-knockout and show
that this causes impairments in neurotransmission. However,
G2019S, one of the most prevalent LRRK2 mutations in
Parkinson’s disease, is known to elevate kinase activity
(Greggio and Cookson, 2009). Interestingly, transfection studies
in human cells have shown that kinase-activating as well as
kinase-dead mutations have similar toxic effects (Cookson and
Bandmann, 2010). Similarly, Shin and colleagues report that
overexpression of LRRK2 slows down synaptic vesicle
endocytosis (Shin et al., 2008). This is in accordance with
previous work from our group, where we showed that in
Drosophila both too much and too little LRRK2 cause
impairments in synaptic vesicle endocytosis (Matta et al.,
2012). Therefore, it is tempting to speculate that LRRK2 is part
of a carefully balanced system, in which both too much and too
little protein activity can cause defects in the synaptic vesicle
cycle. More research is needed to validate this speculation and it
would be interesting to investigate whether our experiments yield
similar results in neurons derived from G2019S LRRK2 knock-in
models.
In conclusion, we unravel an essential role of LRRK2, and in
particular its kinase domain, in the regulation of clathrin-
mediated endocytosis of synaptic vesicles and subsequent
neurotransmission in mammals. We show that a mechanism
that was previously identified in Drosophila melanogaster is




LRRK2-knockout C57Bl6/J mice (Charles River, France) and LRRK2-
knockout Long Evans rats (SAGE Laboratories, USA) were housed under
specific pathogen-free conditions and were used in accordance with
the University of Leuven and Janssen Pharmaceutica Animal Ethics
Committee. For the endocytosis assay and electrophysiology
experiments, wild-type and homozygous LRRK2-knockout animals
were used. Pregnant females were killed by decapitation and embryos
were isolated. For electron microscopy analysis, LRRK2-knockout
animals and wild-type littermates were used. Animals were killed with
CO2 when needed.
SypHy endocytosis assay
Striatal cultures were generated from E17-19 embryos from wild-type
and LRRK2-knockout Long Evans rats (SAGE Laboratories, USA). At
DIV11 primary neurons were co-transfected with sypHy, a fusion
construct of synaptophysin and super ecliptic pHluorin (Granseth et al.,
2006) and pRFP-c-RS (Origine) using Lipofectamin-2000 (Invitrogen,
Gent, Belgium). SypHy is a pH-sensitive fluorescent reporter that, by
analogy with the original synaptopHluorin (synaptobrevin-pHluorin,
(Miesenbo¨ck et al., 1998; Sankaranarayanan and Ryan 2000) is quenched
in the acidic intracellular space of the synaptic vesicles and will only
become fluorescent upon exposure to the more basic pH of the
extravesicular space. In these experiments, only RFP-positive boutons
were assayed for endocytosis in a custom-build stimulation chamber on
the stage of a Zeiss Axiovert 200M equipped with a mono-chromator
(Poly V) and a cooled CCD camera (PCO, Imago QE), both from TILL
Photonics (Gra¨felfing, Germany). The assay was carried out as described
previously (Kim et al., 2005; Sankaranarayanan and Ryan 2000). Briefly,
cells were submerged in 500 ml of HBS buffer (10 mM HEPES,
136 mM NaCl, 2.5 mM KCl, 10 mM D-glucose, 1.3 mM MgCl2,
25 mM NaHCO3, 2 mM CaCl2, pH 7.3). SypHy was excited at
475 nm and its fluorescence emission collected at 525 nm using a 406,
1.1 NA water immersion objective. Images were acquired every half
second for 200 s using TillVision software (TILL Photonics). At frame
15, cells were stimulated for 15 s at 20 Hz. Quantitative measurements of
the fluorescence intensity at individual boutons were obtained by
averaging a selected area of pixel intensities using custom written
macros in Igor Pro (Wavemetrics). Net fluorescence changes (DF) were
obtained by subtracting the average intensity of the first 15 frames (F0)
from the intensity of each frame (Ft) for individual boutons and
normalized to F0 (DF/F0). Both the fluorescence upstroke and decay
were fitted with a single exponential t (tupstroke and tdecay, respectively).
Data are expressed as mean6s.e.m. and statistical significance was
assessed with an unpaired two-tailed Student’s t-test (GraphPad Prism).
Electron microscopy
LRRK2-knockout mice (Charles River, France) and wild-type littermates
(n53 per genotype) were transcardially perfused with 2.5%
glutaraldehyde, 2% paraformaldehyde in 0.1 M cacodylate buffer.
Brains were dissected and post-fixed in the same solution overnight at
4 C˚. Coronal brain sections (300 mm thick) were cut on a vibratome
(Leica, Buffalo Grove, IL) and rectangular pieces of tissue comprising
the striatum were dissected. The tissue was post-fixed with 1% OsO4,
1.5% K4Fe(CN)6 in 0.1 M cacodylate buffer, rinsed, stained with 3%
uranyl acetate and dehydrated in graded ethanols and propyleneoxide,
followed by embedding in EMbed812. Ultrathin sections (70–90 nm)
were obtained using an ultramicrotome (Leica), mounted on copper grids
and treated with uranyl acetate and lead citrate before being imaged using
a JEM-1400 transmission electron microscope (Jeol, Zaventem,
Belgium), equipped with a 11Mpixel Olympus SIS Quemesa camera.
Images were taken at a 300006 magnification, and morphometry and
measurements were performed with ImageJ software. For analysis of
synaptic vesicle numbers, 14830 vesicles in total from 112 wild-type and
115 knockout synapses from the six brain samples (n53 per genotype)
were counted. Synapses were selected based on the presence of an active
zone and all synaptic vesicles present within the synaptic vesicle cluster
were counted. For analysis of synaptic vesicle diameters, a total of 1043
wild-type and 1040 knockout vesicles from the same brain samples used
for the synaptic vesicle counts were measured. Statistical significance
was assessed by Student’s t-test (GraphPad Prism) and data are expressed
as mean6s.e.m.
Electrophysiology
For patch-clamp experiments, hippocampal neurons were derived from
E17–E19 embryos from wild-type and LRRK2-knockout C57Bl6/J mice
(Charles River, France). Cells were plated in a density of 50,000 cells per
ml on cover glasses. Cultures were maintained in neurobasal medium
with B27 supplement (Life Technologies, Gent, Belgium) for 7–12 days,
after which recordings were performed in bath solution (140 mM NaCl,
2.4 mM KCl, 10 mM HEPES, 10 mM glucose, 2.5 mM CaCl2, 1.3 mM
MgCl2, pH 7.3). Pyramidal neurons were voltage clamped under an
Axioskop 2FS upright microscope (Carl Zeiss, Nossegem, Belgium) at a
holding potential of 270 mV using HEKA software. Electrodes (thick-
walled borosilicate glass capillaries with an outer diameter of 1.5 mm
and an inner diameter of 0.86 mm, Harvard Apparatus) were pulled with
a P97 Flaming/Brown Micropipette puller (Sutter Instruments).
Micropipette tips were heated with a micro forge to produce a smooth
surface, with a diameter and resistance of 1 mm and 3–5 MV. Total
sEPSCs were recorded in the absence of TTX to collect all possible
synaptic activities including action-potential-mediated vesicle release.
Events were recorded with intracellular solution (146 mM K-gluconate,
17.80 mM HEPES, 4 mM Mg-ATP, 0.30 mM Na2-ATP, 1 mM EGTA
and 12 mM phosphocreatine, pH 7.3) (Rost et al., 2010) for 10 s with an
EPC10 USB Patch Clamp Amplifier (HEKA). Liquid junctional potential
and series resistance were automatically compensated before each
recording. To further ensure the recorded cells were indeed neurons,
firing patterns were routinely determined at the beginning of each
experiment by introducing depolarization steps. Directly after obtaining a
whole-cell patch configuration, a 1-min recording of baseline activities
was made. After recording baseline activities, bath solution was replaced
by hypertonic solution (bath solution with 50 mM sucrose) by perfusion.
Sucrose is known to increase exocytosis, and consequently endocytosis,
leading to an increase in instantaneous frequency of sEPSCs (Geppert
et al., 1994; Rosenmund and Stevens, 1996). After 2 min in hypertonic
solution, new recordings were made and all measured sEPSCs are
thought to come from newly endocytosed vesicles. For dynasore
experiments, cells were incubated in bath solution containing 40 mM
dynasore for 5 min before recordings were made. After the first
recordings, neurons were incubated in hypertonic solution with added
40 mM dynasore. After 2 min, new recordings were made. All
experiments were performed at room temperature. All measurements
were analyzed using Igor Pro software (Wavemetrics). Data are
expressed as mean6s.e.m. from n cells. Statistical significance was
assessed by two-tailed Student’s t-test (GraphPad Prism).
In vitro phosphorylation assay
Recombinant GST-tagged LRRK2 protein (Life Technologies) and GST-
tagged substrates (Abnova, Taipei, Taiwan, or Dario Alessi, University of
Dundee, Dundee, UK) were incubated in kinase buffer (50 mM Tris-HCl
pH 7.5, 1 mM EGTA, 10 mM MgCl2, 2 mM DTT, 0.01% Tween-20)
in the presence of 1 mM ATP (with 0.5 mCi [33P]ATP, Perkin Elmer,
Zaventem, Belgium) during the indicated time points at 37 C˚. Reactions
were stopped by adding SDS-PAGE sample buffer. Proteins were
separated by electrophoresis on 4–12% NuPAGE gradient gels and
electroblotted onto nitrocellulose membranes. Phosphorylation of
substrates was quantified using Typhoon (GE Healthcare, Belgium)
and total protein levels were determined by western blotting using an
anti-GST antibody (Sigma-Aldrich, Diegem, Belgium). Data are
expressed as mean6s.e.m. Statistical significance was assessed by two-
way ANOVA with Bonferroni post-test (GraphPad Prism).
Phosphopeptide analysis by LC-MS/MS
LRRK2 (recombinant protein; Life Technologies) was used in an in vitro
phosphorylation assay in the presence or absence of human SH3GL2.
Protein samples were separated by SDS-PAGE and stained with
Coomassie Brilliant Blue G-250. Excised gel bands were washed with
water, followed by 50% acetonitrile and acetonitrile before vacuum
drying. Bands were cut in two and one half was fully submerged in
digestion buffer (50 mM NH4HCO3 in 10% acetonitrile) with 0.1 mg
trypsin (Promega) for in-gel digestion. Digestion proceeded overnight at
37 C˚, following which the generated peptide mixtures were acidified with
formic acid. The other half of the protein band was first N-propionylated
in-gel before digestion with trypsin, as in this way, side-chains of lysines
are blocked (indicated in the supplementary material Table S1 as
,prop*.) and no longer recognized by trypsin, which then only cleaves
C-terminal to arginines. All peptide mixtures were then analyzed by
LC-MS/MS using a LTQ Orbitrap XL mass spectrometer (Thermo
Scientific). The generated MS/MS spectra were searched in the human
subsection of the Swiss-Prot database by the Mascot algorithm. For
phosphopeptide enrichment, TiO2 Mag Sepharose beads (GE Healthcare)
were used prior to LC-MS/MS analysis.
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